Article Information
History
- August 17, 2020.
Article Versions
- Version 1 (August 1, 2020 - 23:00).
- You are currently viewing Version 2 of this article (August 17, 2020 - 11:37).
- Version 3 (November 12, 2020 - 09:12).
- Version 4 (December 21, 2020 - 13:19).
- View Version 5, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Matti O. Ruuskanen1,2,*,
- Fredrik Åberg3,4,
- Ville Männistö5,6,
- Aki S. Havulinna2,7,
- Guillaume Méric8,9,
- Yang Liu8,10,
- Rohit Loomba11,12,
- Yoshiki Vázquez-Baeza13,14,
- Anupriya Tripathi15,16,17,
- Liisa M. Valsta2,
- Michael Inouye8,18,
- Pekka Jousilahti2,
- Veikko Salomaa2,
- Mohit Jain12,19,
- Rob Knight13,14,20,21,
- Leo Lahti22 and
- Teemu J. Niiranen1,2,23
- 1Department of Internal Medicine, University of Turku, Turku, Finland
- 2Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland
- 3Transplantation and Liver Surgery Clinic, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
- 4The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden
- 5Department of Medicine, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland
- 6Department of Experimental Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
- 7Institute for Molecular Medicine Finland, FIMM - HiLIFE, Helsinki, Finland
- 8Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
- 9Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia
- 10Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia
- 11Department of Medicine, NAFLD Research Center, La Jolla, CA, USA
- 12Department of Medicine, University of California, San Diego, La Jolla, CA, USA
- 13Jacobs School of Engineering, University of California, San Diego, La Jolla, CA, USA
- 14Center for Microbiome Innovation, University of California San Diego, La Jolla, California, USA
- 15Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, USA
- 16Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, USA
- 17Division of Biological Sciences, University of California, San Diego, La Jolla, California, USA
- 18Department of Public Health and Primary Care, Cambridge University, Cambridge, United Kingdom
- 19Department of Pharmacology, University of California San Diego, La Jolla, California, USA
- 20Department of Pediatrics, School of Medicine, University of California San Diego, La Jolla, California, USA
- 21Department of Computer Science & Engineering, University of California San Diego, La Jolla, California, USA
- 22Department of Future Technologies, University of Turku, Turku, Finland
- 23Division of Medicine, Turku University Hospital, Turku, Finland
- ↵*Correspondence: Matti Ruuskanen, matti.ruuskanen{at}utu.fi
Posted August 17, 2020.
Links between gut microbiome composition and fatty liver disease in a large population sample
